Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › South Dakota › Sioux Falls
Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Sioux Falls, SD keessatti
Qorannoo 3 Kansera Urothelial (Cell Transitional) f Sioux Falls fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Avera Cancer Institute, Sioux Falls
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Avera Medical Group, Sioux Falls
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- Avera Cancer Institute- Research, Sioux Falls
Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti
- Nashville, TNQorannoo 23
- New York City, NYQorannoo 22
- Houston, TXQorannoo 19
- Dallas, TXQorannoo 18
- Edison, NJQorannoo 18
- Los Angeles, CAQorannoo 17
- Queens, NYQorannoo 15
- Chicago, ILQorannoo 14
- Arlington, VAQorannoo 12
- Boston, MAQorannoo 11
- San Antonio, TXQorannoo 11
- Austin, TXQorannoo 10
Qorannoo biroo Sioux Falls keessatti
- Kansara Qara'a Non-Small CellQorannoo 19
- Saree OljooQorannoo 18
- Kansarii OvariiQorannoo 16
- Dhibee QaraQorannoo 14
- Saree (Gosoota Hunda)Qorannoo 13
- Kansa EndometiriyaaliiQorannoo 11
- Kansara MetastatikiiQorannoo 10
- Kansarii ColorectalQorannoo 9
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 9
- Cufama OnneeQorannoo 7
- Kansarii KoloniiQorannoo 7
- Kansaar Onnee Triple-NegativeQorannoo 7
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.